NasdaqGS - Nasdaq Real Time Price USD

Prelude Therapeutics Incorporated (PRLD)

0.9820
+0.0583
+(6.31%)
At close: May 20 at 4:00:00 PM EDT
0.9329
-0.05
(-5.00%)
After hours: May 20 at 5:01:31 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
7,000
7,000
0
0
0
Operating Expense
146,977
146,714
132,277
123,540
113,735
Operating Income
-139,977
-139,714
-132,277
-123,540
-113,735
Other Income Expense
12,150
12,541
10,445
8,102
2,041
Pretax Income
-127,827
-127,173
-121,832
-115,438
-111,694
Net Income Common Stockholders
-127,827
-127,173
-121,832
-115,438
-111,694
Diluted NI Available to Com Stockholders
-127,827
-127,173
-121,832
-115,438
-111,694
Basic EPS
-1.68
--
-2.02
-2.44
-2.43
Diluted EPS
-1.68
--
-2.02
-2.44
-2.43
Basic Average Shares
75,868.4220
--
60,357.0520
47,371.5890
46,049.7630
Diluted Average Shares
75,868.4220
--
60,357.0520
47,371.5890
46,049.7630
Total Operating Income as Reported
-139,977
-139,714
-132,277
-123,540
-113,735
Total Expenses
146,977
146,714
132,277
123,540
113,735
Net Income from Continuing & Discontinued Operation
-127,827
-127,173
-121,832
-115,438
-111,694
Normalized Income
-127,827
-127,173
-121,832
-115,438
-111,694
EBIT
-139,977
-139,714
-132,277
-123,540
-113,735
EBITDA
-138,196
-137,942
-131,108
-122,216
-112,820
Reconciled Depreciation
1,781
1,772
1,169
1,324
915
Net Income from Continuing Operation Net Minority Interest
-127,827
-127,173
-121,832
-115,438
-111,694
Normalized EBITDA
-138,196
-137,942
-131,108
-122,216
-112,820
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/25/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STTK Shattuck Labs, Inc.
1.0300
-1.90%
 
FHTX Foghorn Therapeutics Inc.
4.1400
-1.66%
 
ARTV Artiva Biotherapeutics, Inc.
2.1600
+6.93%
 
RAPP Rapport Therapeutics, Inc.
10.22
+0.29%
 
KOD Kodiak Sciences Inc.
4.0600
+9.43%
 
IDYA IDEAYA Biosciences, Inc.
19.63
+8.57%
 
PHGE BiomX Inc.
0.5462
-1.09%
 
INCY Incyte Corporation
65.30
+2.34%
 
IMCR Immunocore Holdings plc
32.39
+4.48%
 
IKNA Ikena Oncology, Inc.
1.1300
+1.80%